Even though all income is taxed, the rate at which it is taxed - and even how often it is taxed - is something that the average dermatologist has some degree of control over. All too often, money withdrawn from the dermatology practice may be eaten up by taxes before it reaches the dermatologist's pockets. On the other hand, excessive earnings and profits, if left in the practice, may trigger expensive tax penalties.
The FDA approved therapies for melanoma, dermatomyositis, superficial basal cell carcinoma, and adolescent alopecia areata, while TYK2 inhibitors and rare disease filings advanced toward 2027 decisions.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
The FDA approval, based on 36-week data from the phase 3 BRAVE-AA-PEDS trial, extends baricitinib access to patients as young as 12 years old with severe alopecia areata.